Innate Pharma OverviewInnate Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for IPHA.
Quarterly EBIT
-$31.38M
↓ 38.89% YoY
As of Dec 31, 2025
Annual EBIT (TTM)
-$92.55M
↓ 121.95% YoY
Trailing 12 months ending Dec 31, 2025
Innate Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for IPHA.
As of Dec 31, 2025
Trailing 12 months ending Dec 31, 2025